113 related articles for article (PubMed ID: 37172427)
1. FATP2 regulates non-small cell lung cancer by mediating lipid metabolism through ACSL1.
Chen Y; Zhao Y; Deng Y; Yang Y; Xu L; Fu J
Tissue Cell; 2023 Jun; 82():102105. PubMed ID: 37172427
[TBL] [Abstract][Full Text] [Related]
2. ACSL1-Mediated Fatty Acid β-Oxidation Enhances Metastasis and Proliferation in Endometrial Cancer.
Zhou Y; Li Y; Chen G; Guo X; Gao X; Meng J; Xu Y; Zhou N; Zhang B; Zhou X
Front Biosci (Landmark Ed); 2024 Feb; 29(2):66. PubMed ID: 38420815
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of Nrf2 accelerates renal lipid deposition through suppressing the ACSL1 expression in obesity-related nephropathy.
Chen Y; He L; Yang Y; Chen Y; Song Y; Lu X; Liang Y
Ren Fail; 2019 Nov; 41(1):821-831. PubMed ID: 31488013
[No Abstract] [Full Text] [Related]
4. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells.
Krammer J; Digel M; Ehehalt F; Stremmel W; Füllekrug J; Ehehalt R
Int J Med Sci; 2011; 8(7):599-614. PubMed ID: 22022213
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
[TBL] [Abstract][Full Text] [Related]
7. FATP2-targeted therapies - A role beyond fatty liver disease.
Qiu P; Wang H; Zhang M; Zhang M; Peng R; Zhao Q; Liu J
Pharmacol Res; 2020 Nov; 161():105228. PubMed ID: 33027714
[TBL] [Abstract][Full Text] [Related]
8. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis.
Chen Y; Yan Q; Lv M; Song K; Dai Y; Huang Y; Zhang L; Zhang C; Gao H
Cell Death Dis; 2020 Nov; 11(11):994. PubMed ID: 33219209
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids.
Melton EM; Cerny RL; DiRusso CC; Black PN
Biochem Biophys Res Commun; 2013 Nov; 440(4):743-8. PubMed ID: 24113382
[TBL] [Abstract][Full Text] [Related]
10. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
11. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Chen WC; Wang CY; Hung YH; Weng TY; Yen MC; Lai MD
PLoS One; 2016; 11(5):e0155660. PubMed ID: 27171439
[TBL] [Abstract][Full Text] [Related]
12. ACSL1 affects Triglyceride Levels through the PPARγ Pathway.
Li T; Li X; Meng H; Chen L; Meng F
Int J Med Sci; 2020; 17(6):720-727. PubMed ID: 32218693
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo.
Parkes HA; Preston E; Wilks D; Ballesteros M; Carpenter L; Wood L; Kraegen EW; Furler SM; Cooney GJ
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E737-44. PubMed ID: 16705061
[TBL] [Abstract][Full Text] [Related]
14. Effects of Long-Chain Fatty Acyl-CoA Synthetase 1 on Diglyceride Synthesis and Arachidonic Acid Metabolism in Sheep Adipocytes.
Cao Y; Wang S; Liu S; Wang Y; Jin H; Ma H; Luo X; Cao Y; Lian Z
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192050
[TBL] [Abstract][Full Text] [Related]
15. Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling.
Yang G; Wang Y; Feng J; Liu Y; Wang T; Zhao M; Ye L; Zhang X
Biochem Biophys Res Commun; 2017 May; 486(3):827-832. PubMed ID: 28359761
[TBL] [Abstract][Full Text] [Related]
16. Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
Fernández LP; Merino M; Colmenarejo G; Moreno-Rubio J; Sánchez-Martínez R; Quijada-Freire A; Gómez de Cedrón M; Reglero G; Casado E; Sereno M; Ramírez de Molina A
Mol Oncol; 2020 Dec; 14(12):3135-3152. PubMed ID: 33030783
[TBL] [Abstract][Full Text] [Related]
17. Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
Goldenberg JR; Wang X; Lewandowski ED
J Mol Cell Cardiol; 2016 May; 94():1-9. PubMed ID: 26995156
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease.
Ran LS; Wu YZ; Gan YW; Wang HL; Wu LJ; Zheng CM; Ming Y; Xiong R; Li YL; Lei SH; Wang X; Lao XQ; Zhang HM; Wang L; Chen C; Zhao CY
J Nat Med; 2023 Jan; 77(1):73-86. PubMed ID: 36115008
[TBL] [Abstract][Full Text] [Related]
19. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression.
Li B; Liu J; Xin X; Zhang L; Zhou J; Xia C; Zhu W; Yu H
Int J Med Sci; 2021; 18(3):615-625. PubMed ID: 33437196
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.
Paul DS; Grevengoed TJ; Pascual F; Ellis JM; Willis MS; Coleman RA
Biochim Biophys Acta; 2014 Jun; 1841(6):880-7. PubMed ID: 24631848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
